HEADER TRANSCRIPTION/INHIBITOR 19-JUL-13 3WFF TITLE MINERALOCORTICOID RECEPTOR LIGAND-BINDING DOMAIN WITH COMPOUND 2B COMPND MOL_ID: 1; COMPND 2 MOLECULE: MINERALOCORTICOID RECEPTOR; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: LIGAND-BINDING DOMAIN, UNP RESIDUES 712-984; COMPND 5 SYNONYM: MR, NUCLEAR RECEPTOR SUBFAMILY 3 GROUP C MEMBER 2; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: NR3C2, MCR, MLR; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PRTH6 KEYWDS NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, TRANSCRIPTION, HYPERTENSION, KEYWDS 2 NON-STEROIDAL ANTAGONIST, ACTIVATING MUTATION, TRANSCRIPTION- KEYWDS 3 INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR S.SOGABE,N.HABUKA REVDAT 4 08-NOV-23 3WFF 1 REMARK REVDAT 3 23-SEP-20 3WFF 1 TITLE REMARK REVDAT 2 25-DEC-19 3WFF 1 JRNL SEQADV REVDAT 1 21-AUG-13 3WFF 0 JRNL AUTH T.HASUI,T.OHRA,N.OHYABU,K.ASANO,H.MATSUI,A.MIZUKAMI, JRNL AUTH 2 N.HABUKA,S.SOGABE,S.ENDO,C.S.SIEDEM,T.P.TANG,C.GAUTHIER, JRNL AUTH 3 L.A.DE MEESE,S.A.BOYD,S.FUKUMOTO JRNL TITL DESIGN, SYNTHESIS, AND STRUCTURE-ACTIVITY RELATIONSHIPS OF JRNL TITL 2 DIHYDROFURAN-2-ONE AND DIHYDROPYRROL-2-ONE DERIVATIVES AS JRNL TITL 3 NOVEL BENZOXAZIN-3-ONE-BASED MINERALOCORTICOID RECEPTOR JRNL TITL 4 ANTAGONISTS. JRNL REF BIOORG.MED.CHEM. V. 21 5983 2013 JRNL REFN ESSN 1464-3391 JRNL PMID 23958516 JRNL DOI 10.1016/J.BMC.2013.07.043 REMARK 2 REMARK 2 RESOLUTION. 2.05 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.7.0032 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.05 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 33.86 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 3 NUMBER OF REFLECTIONS : 20007 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.188 REMARK 3 R VALUE (WORKING SET) : 0.186 REMARK 3 FREE R VALUE : 0.216 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 1082 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.05 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.10 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1408 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.34 REMARK 3 BIN R VALUE (WORKING SET) : 0.2320 REMARK 3 BIN FREE R VALUE SET COUNT : 95 REMARK 3 BIN FREE R VALUE : 0.2480 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2109 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 30 REMARK 3 SOLVENT ATOMS : 94 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 38.81 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -12.66000 REMARK 3 B22 (A**2) : -12.66000 REMARK 3 B33 (A**2) : 25.32000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.037 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.032 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.086 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 6.174 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.962 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.944 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2214 ; 0.009 ; 0.019 REMARK 3 BOND LENGTHS OTHERS (A): 2118 ; 0.001 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3004 ; 1.404 ; 1.986 REMARK 3 BOND ANGLES OTHERS (DEGREES): 4890 ; 0.720 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 263 ; 4.643 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 99 ;32.885 ;24.545 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 407 ;13.109 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 9 ;14.429 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 330 ; 0.067 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2482 ; 0.005 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): 515 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1037 ; 1.532 ; 2.884 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 1036 ; 1.530 ; 2.884 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 1296 ; 2.262 ; 4.315 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): 1297 ; 2.261 ; 4.316 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1177 ; 2.252 ; 3.154 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): 1174 ; 2.252 ; 3.152 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): 1700 ; 3.470 ; 4.615 REMARK 3 LONG RANGE B REFINED ATOMS (A**2): 2698 ; 5.044 ;23.594 REMARK 3 LONG RANGE B OTHER ATOMS (A**2): 2673 ; 5.028 ;23.438 REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 2 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 735 A 984 REMARK 3 RESIDUE RANGE : A 1001 A 1001 REMARK 3 ORIGIN FOR THE GROUP (A): 7.3587 14.2103 53.9447 REMARK 3 T TENSOR REMARK 3 T11: 0.1428 T22: 0.0788 REMARK 3 T33: 0.0069 T12: -0.0658 REMARK 3 T13: 0.0075 T23: 0.0106 REMARK 3 L TENSOR REMARK 3 L11: 0.3260 L22: 0.7796 REMARK 3 L33: 0.4465 L12: 0.1302 REMARK 3 L13: -0.0646 L23: -0.3042 REMARK 3 S TENSOR REMARK 3 S11: -0.0951 S12: 0.0545 S13: 0.0048 REMARK 3 S21: -0.1182 S22: 0.0929 S23: -0.0179 REMARK 3 S31: 0.0233 S32: 0.0243 S33: 0.0022 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 3WFF COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 06-AUG-13. REMARK 100 THE DEPOSITION ID IS D_1000096267. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-SEP-07 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.2 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALS REMARK 200 BEAMLINE : 5.0.3 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 210R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 21157 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.050 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 7.400 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.07900 REMARK 200 FOR THE DATA SET : 23.1000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.05 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.10 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.4 REMARK 200 DATA REDUNDANCY IN SHELL : 6.60 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.48400 REMARK 200 FOR SHELL : 3.400 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: 3VHV REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 51.34 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.53 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.04M POTASSIUM DIHYDROGEN PHOSPHATE, REMARK 280 16% PEG 8000, 20% GLYCEROL, PH 7.2, VAPOR DIFFUSION, SITTING REMARK 280 DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 31 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+1/3 REMARK 290 3555 -X+Y,-X,Z+2/3 REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z+2/3 REMARK 290 6555 -X,-X+Y,-Z+1/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 68.71767 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 137.43533 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 137.43533 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 68.71767 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 710 REMARK 465 SER A 711 REMARK 465 ALA A 712 REMARK 465 PRO A 713 REMARK 465 ALA A 714 REMARK 465 LYS A 715 REMARK 465 GLU A 716 REMARK 465 PRO A 717 REMARK 465 SER A 718 REMARK 465 VAL A 719 REMARK 465 ASN A 720 REMARK 465 THR A 721 REMARK 465 ALA A 722 REMARK 465 LEU A 723 REMARK 465 VAL A 724 REMARK 465 PRO A 725 REMARK 465 GLN A 726 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OE1 GLU A 746 O HOH A 1180 2.07 REMARK 500 OG SER A 737 O HOH A 1178 2.15 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LEU A 833 88.00 -150.69 REMARK 500 MET A 845 54.05 -142.18 REMARK 500 SER A 888 78.15 -111.92 REMARK 500 ASN A 912 -142.05 53.79 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE WFF A 1001 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PO4 A 1002 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3VHU RELATED DB: PDB REMARK 900 RELATED ID: 3VHV RELATED DB: PDB REMARK 900 RELATED ID: 3WFG RELATED DB: PDB DBREF 3WFF A 712 984 UNP P08235 MCR_HUMAN 712 984 SEQADV 3WFF GLY A 710 UNP P08235 EXPRESSION TAG SEQADV 3WFF SER A 711 UNP P08235 EXPRESSION TAG SEQADV 3WFF SER A 808 UNP P08235 CYS 808 ENGINEERED MUTATION SEQADV 3WFF LEU A 810 UNP P08235 SER 810 ENGINEERED MUTATION SEQADV 3WFF VAL A 976 UNP P08235 ALA 976 ENGINEERED MUTATION SEQRES 1 A 275 GLY SER ALA PRO ALA LYS GLU PRO SER VAL ASN THR ALA SEQRES 2 A 275 LEU VAL PRO GLN LEU SER THR ILE SER ARG ALA LEU THR SEQRES 3 A 275 PRO SER PRO VAL MET VAL LEU GLU ASN ILE GLU PRO GLU SEQRES 4 A 275 ILE VAL TYR ALA GLY TYR ASP SER SER LYS PRO ASP THR SEQRES 5 A 275 ALA GLU ASN LEU LEU SER THR LEU ASN ARG LEU ALA GLY SEQRES 6 A 275 LYS GLN MET ILE GLN VAL VAL LYS TRP ALA LYS VAL LEU SEQRES 7 A 275 PRO GLY PHE LYS ASN LEU PRO LEU GLU ASP GLN ILE THR SEQRES 8 A 275 LEU ILE GLN TYR SER TRP MET SER LEU LEU SER PHE ALA SEQRES 9 A 275 LEU SER TRP ARG SER TYR LYS HIS THR ASN SER GLN PHE SEQRES 10 A 275 LEU TYR PHE ALA PRO ASP LEU VAL PHE ASN GLU GLU LYS SEQRES 11 A 275 MET HIS GLN SER ALA MET TYR GLU LEU CYS GLN GLY MET SEQRES 12 A 275 HIS GLN ILE SER LEU GLN PHE VAL ARG LEU GLN LEU THR SEQRES 13 A 275 PHE GLU GLU TYR THR ILE MET LYS VAL LEU LEU LEU LEU SEQRES 14 A 275 SER THR ILE PRO LYS ASP GLY LEU LYS SER GLN ALA ALA SEQRES 15 A 275 PHE GLU GLU MET ARG THR ASN TYR ILE LYS GLU LEU ARG SEQRES 16 A 275 LYS MET VAL THR LYS CYS PRO ASN ASN SER GLY GLN SER SEQRES 17 A 275 TRP GLN ARG PHE TYR GLN LEU THR LYS LEU LEU ASP SER SEQRES 18 A 275 MET HIS ASP LEU VAL SER ASP LEU LEU GLU PHE CYS PHE SEQRES 19 A 275 TYR THR PHE ARG GLU SER HIS ALA LEU LYS VAL GLU PHE SEQRES 20 A 275 PRO ALA MET LEU VAL GLU ILE ILE SER ASP GLN LEU PRO SEQRES 21 A 275 LYS VAL GLU SER GLY ASN VAL LYS PRO LEU TYR PHE HIS SEQRES 22 A 275 ARG LYS HET WFF A1001 25 HET PO4 A1002 5 HETNAM WFF 6-[4-(2,4-DIFLUOROPHENYL)-5-OXO-2,5-DIHYDROFURAN-3-YL]- HETNAM 2 WFF 2H-1,4-BENZOXAZIN-3(4H)-ONE HETNAM PO4 PHOSPHATE ION FORMUL 2 WFF C18 H11 F2 N O4 FORMUL 3 PO4 O4 P 3- FORMUL 4 HOH *94(H2 O) HELIX 1 1 SER A 728 THR A 735 1 8 HELIX 2 2 SER A 737 ILE A 745 1 9 HELIX 3 3 THR A 761 VAL A 786 1 26 HELIX 4 4 GLY A 789 LEU A 793 5 5 HELIX 5 5 PRO A 794 ASN A 823 1 30 HELIX 6 6 ASN A 836 SER A 843 1 8 HELIX 7 7 MET A 845 GLN A 863 1 19 HELIX 8 8 THR A 865 LEU A 878 1 14 HELIX 9 9 SER A 888 CYS A 910 1 23 HELIX 10 10 PRO A 911 GLY A 915 5 5 HELIX 11 11 GLN A 916 GLU A 948 1 33 HELIX 12 12 GLU A 948 LYS A 953 1 6 HELIX 13 13 PRO A 957 SER A 973 1 17 SHEET 1 A 2 LEU A 827 ALA A 830 0 SHEET 2 A 2 LEU A 833 PHE A 835 -1 O PHE A 835 N LEU A 827 SHEET 1 B 2 THR A 880 ILE A 881 0 SHEET 2 B 2 LYS A 977 PRO A 978 -1 O LYS A 977 N ILE A 881 SITE 1 AC1 17 LEU A 769 ASN A 770 ALA A 773 MET A 807 SITE 2 AC1 17 SER A 811 LEU A 814 PHE A 829 MET A 845 SITE 3 AC1 17 LEU A 848 MET A 852 LEU A 938 PHE A 941 SITE 4 AC1 17 CYS A 942 THR A 945 VAL A 954 PHE A 956 SITE 5 AC1 17 HOH A1118 SITE 1 AC2 6 TYR A 846 PHE A 981 HIS A 982 ARG A 983 SITE 2 AC2 6 HOH A1149 HOH A1151 CRYST1 51.866 51.866 206.153 90.00 90.00 120.00 P 31 2 1 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.019280 0.011132 0.000000 0.00000 SCALE2 0.000000 0.022263 0.000000 0.00000 SCALE3 0.000000 0.000000 0.004851 0.00000